75 filings
8-K
SRRK
Scholar Rock Holding Corp
22 May 24
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
8:30am
8-K
SRRK
Scholar Rock Holding Corp
14 May 24
Entry into a Material Definitive Agreement
7:15am
8-K
SRRK
Scholar Rock Holding Corp
7 May 24
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
7:20am
8-K
SRRK
Scholar Rock Holding Corp
19 Mar 24
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
7:07am
8-K
SRRK
Scholar Rock Holding Corp
15 Feb 24
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
8:57am
8-K
9qxn7vc 2wi0ee3pt8
8 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
iyt76h40ww 9eo
7 Nov 23
Results of Operations and Financial Condition
7:15am
8-K
wav21hfk
12 Oct 23
Scholar Rock Announces Proposed Public Offering of Common Stock
5:02pm
8-K
fspfln0lm
11 Oct 23
Scholar Rock TO ADVANCE ANTIMYOSTATIN PROGRAM to develop novel therapies for CARDIOMETABOLIC DISORDERS
4:48pm
8-K
abx gnfyxsp
9 Aug 23
Results of Operations and Financial Condition
4:16pm
8-K
y88vp1 armkz8dv
30 Jun 23
Regulation FD Disclosure
11:04am
8-K
6uhlalb9
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
lp43cd9ochrjq7n
9 May 23
Results of Operations and Financial Condition
7:30am
8-K
m79irymi84b8cfo ur
10 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
i4xvtv06hxa
10 Mar 23
Regulation FD Disclosure
6:39pm
8-K
j60iig6vv
7 Mar 23
Results of Operations and Financial Condition
7:50am
8-K
5cy787y2u216encd7 iz
9 Jan 23
Regulation FD Disclosure
8:01am
8-K
7qg4wl5f6 8zu3u1
14 Nov 22
Results of Operations and Financial Condition
8:00am
8-K
56vxk0f
9 Nov 22
Departure of Directors or Certain Officers
8:00am
8-K
166bjf31f6
20 Sep 22
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
7:10am